The revised offer is the merit of those single shareholders giving management a kick in the backside and showing resistance ! I'm still sadden that a organised resistance of retail shareholders wasn't possible.
Interesting that the Share Price is performing only moderate after this news and is still approx. 20% below the new ECE offer.
Mr. Market is still not enthusiastic about this deal.
Sumich and ECE have to deliver more positive FACTS in the coming report/Investor presentation.
- Forums
- ASX - By Stock
- GBE
- ece revised to 40.5 cents
ece revised to 40.5 cents, page-8
Featured News
Add GBE (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $29.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 131159 | 4.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.6¢ | 48273 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 131159 | 0.042 |
4 | 54149 | 0.037 |
3 | 133700 | 0.030 |
1 | 400000 | 0.025 |
1 | 1600000 | 0.005 |
Price($) | Vol. | No. |
---|---|---|
0.046 | 48273 | 1 |
0.060 | 60000 | 1 |
0.080 | 460 | 1 |
0.090 | 31657 | 1 |
0.000 | 0 | 0 |
Last trade - 16.12pm 15/11/2024 (20 minute delay) ? |
Featured News
GBE (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online